Navigation
Search
|
Moderna Says mRNA Flu Vaccine Sailed Through Trial, Beating Standard Shot
Saturday July 5, 2025. 01:30 AM , from Slashdot
![]() The company announced that mRNA-1010 had an overall vaccine efficacy that was 26.6% higher than conventional shots, rising to 27.4% higher in participants aged 65 and older during the six-month study period. The 2024-2025 flu season hospitalized an estimated 770,000 Americans, according to the Centers for Disease Control and Prevention. Read more of this story at Slashdot.
https://science.slashdot.org/story/25/07/04/1753246/moderna-says-mrna-flu-vaccine-sailed-through-tri...
Related News |
25 sources
Current Date
Jul, Sat 5 - 10:40 CEST
|